In contrast to breast cancer, CYP27A1 expression is negatively associated with aggressiveness of prostate cancer; patients whose tumors express higher CYP27A1 mRNA exhibit lower tumor grade and longer disease-free survival (253). This evidence concerns the gene CYP27A1 and neoplasm.